Oscar is highlighted as a healthcare stock with massive upside potential, with the creator actively adding to their position and expecting significant price appreciation.
Source Post
Novo Nordisk ($NVO) Game Changing UnitedHealth Group ($UNH) Watch EPS
The RoseApr 15, 2026
The creator discusses the competitive landscape in the weight loss drug market, favoring Novo Nordisk ($NVO) over Eli Lilly due to efficacy and a new subscription model. They also analyze UnitedHealth Group ($UNH), believing its stock is undervalued despite concerns about health insurance usage and premium increases. The creator holds positions in both UNH and NVO, seeing significant upside potential for both companies.
Linked Mentions
Tickers discussed in this post
Eli Lilly's new oral weight loss pill, Found A O, is positioned as a maintenance drug rather than a primary efficacy solution, and faces challenges from Novo Nordisk's superior product and market strategy.
UnitedHealth Group's stock is seen as significantly undervalued due to market overreaction to increased health insurance usage and premium hikes, with potential for substantial price appreciation.
Novo Nordisk is favored due to its superior efficacy in weight loss drugs, a new subscription model that offers stable revenue, and strategic partnerships, suggesting significant upside potential.